Vasiliki Leventaki, MD

Assistant Professor

view physician profile

Locations

Pathology - Froedtert Hospital
Pathology - Children's

Specialties

Hematopathology

Languages

English

Education

MD - Doctor of Medicine

Biography

Dr. Leventaki received an MD from the National and Kapodistrian University of Athens in Greece. She completed a two-year postdoctoral research fellowship in the laboratory of Dr. Rassidakis at MD Anderson Cancer Center investigating molecular mechanism involved in the pathogenesis of anaplastic large cell lymphoma (ALCL). She trained as a resident in Anatomic and Clinical Pathology at the University of Utah and pursued subspecialty fellowship in hematopathology at MD Anderson Cancer Center. After her fellowship, she joined the Department of Pathology at St. Jude Childrens Research Hospital from 2013 to 2018. She is currently an Assistant Professor in the Department of Pathology at the Medical College of Wisconsin. Dr. Leventaki’s primary clinical activity in the Hematopathology service at Froedtert Hospital and Children’s Hospital of Wisconsin, and she actively participates in pathology resident and hematopathology and pediatric Hematology/Oncology fellows education. She also serves as the technical director of the hematology and flow cytometry laboratories at Children’s Hospital of Wisconsin. Dr. Leventaki’s major research interests include investigation of molecular mechanisms altered in pediatric lymphomas and their role in lymphomagenesis.

Pathology and genetics of anaplastic large cell lymphoma.

(Leventaki V, Bhattacharyya S, Lim MS.) Semin Diagn Pathol. 2020 Jan;37(1):57-71 PMID: 31882178 SCOPUS ID: 2-s2.0-85076851134 12/29/2019
MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer.

(Wang S, Oh DY, Leventaki V, Drakos E, Zhang R, Sahin AA, Resetkova E, Edgerton ME, Wu W, Claret FX.) Cancer Lett. 2019 11 28;465:12-23 PMID: 31473252 SCOPUS ID: 2-s2.0-85071611443 09/02/2019
AP-1 Transcription Factors as Regulators of Immune Responses in Cancer.

(Atsaves V, Leventaki V, Rassidakis GZ, Claret FX.) Cancers (Basel). 2019 Jul 23;11(7) PMID: 31340499 PMCID: PMC6678392 07/26/2019
Leukemic presentation of ALK-positive anaplastic large cell lymphoma with a novel partner, poly(A) binding protein cytoplasmic 1 (PABPC1), responding to single-agent crizotinib.

(Graetz D, Crews KR, Azzato EM, Singh RK, Raimondi S, Mason J, Valentine M, Mullighan CG, Holland A, Inaba H, Leventaki V.) Haematologica. 2019 05;104(5):e218-e221 PMID: 30819904 PMCID: PMC6518893 SCOPUS ID: 2-s2.0-85065466454 03/02/2019
Germline deletion of ETV6 in familial acute lymphoblastic leukemia.

(Rampersaud E, Ziegler DS, Iacobucci I, Payne-Turner D, Churchman ML, Schrader KA, Joseph V, Offit K, Tucker K, Sutton R, Warby M, Chenevix-Trench G, Huntsman DG, Tsoli M, Mead RS, Qu C, Leventaki V, Wu G, Mullighan CG.) Blood Adv. 2019 04 09;3(7):1039-1046 PMID: 30940639 PMCID: PMC6457220 SCOPUS ID: 2-s2.0-85068308046 04/04/2019
Two-year-old female with EBV-positive diffuse large B-cell lymphoma and subsequent CNS involvement with neurolymphomatosis.

(Bjornard KL, Leventaki V, Nichols KE, Sandlund JT, Prockop S, Ehrhardt MJ.) Pediatr Blood Cancer. 2018 12;65(12):e27415 PMID: 30151967 PMCID: PMC8244825 SCOPUS ID: 2-s2.0-85052806933 08/29/2018
Sarcoid-like granulomatosis in a patient receiving anti-TNFα for psoriasis.

(Leventaki V, Flerlage J.) Am J Hematol. 2018 05;93(5):722-723 PMID: 29274117 SCOPUS ID: 2-s2.0-85042445589 12/24/2017
PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma.

(Atsaves V, Tsesmetzis N, Chioureas D, Kis L, Leventaki V, Drakos E, Panaretakis T, Grander D, Medeiros LJ, Young KH, Rassidakis GZ.) Leukemia. 2017 07;31(7):1633-1637 PMID: 28344319 SCOPUS ID: 2-s2.0-85017521489 03/28/2017
Novel ALK fusion in anaplastic large cell lymphoma involving EEF1G, a subunit of the eukaryotic elongation factor-1 complex.

(Palacios G, Shaw TI, Li Y, Singh RK, Valentine M, Sandlund JT, Lim MS, Mullighan CG, Leventaki V.) Leukemia. 2017 03;31(3):743-747 PMID: 27840423 PMCID: PMC5639880 SCOPUS ID: 2-s2.0-85008316381 11/15/2016
Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression.

(Pan Y, Wang S, Su B, Zhou F, Zhang R, Xu T, Zhang R, Leventaki V, Drakos E, Liu W, Claret FX.) Oncogene. 2017 02 23;36(8):1069-1079 PMID: 27524414 PMCID: PMC5311075 SCOPUS ID: 2-s2.0-84982123817 08/16/2016
γδ T-Cell Acute Lymphoblastic Leukemia/Lymphoma: Discussion of Two Pediatric Cases and Its Distinction from Other Mature γδ T-Cell Malignancies.

(Wei EX, Leventaki V, Choi JK, Raimondi SC, Azzato EM, Shurtleff SA, Ong MG, Veillon DM, Cotelingam JD, Shackelford RE.) Case Rep Hematol. 2017;2017:5873015 PMID: 29147589 PMCID: PMC5632927 11/18/2017
Unusual magnetic resonance imaging presentation of post-BMT cerebral toxoplasmosis masquerading as meningoencephalitis and ventriculitis.

(Helton KJ, Maron G, Mamcarz E, Leventaki V, Patay Z, Sadighi Z.) Bone Marrow Transplant. 2016 11;51(11):1533-1536 PMID: 27348541 SCOPUS ID: 2-s2.0-84976259432 11/03/2016